Pharma News

The U.S. Food and Drug Administration  approved Vistogard (uridine triacetate) for the emergency treatment of adults and children who receive an overdose of the cancer treatment fluorouracil or capecitabine, or who develop certain severe or life-threatening toxicities within four days of receiving these cancer treatments.

The U.S. Food and Drug Administration approved Alecensa (alectinib) to treat people with advanced (metastatic) ALK-positive non-small cell lung cancer (NSCLC) whose disease has worsened after, or who could not tolerate treatment with, another therapy called Xalkori (crizotinib).

Scientists have found that continued semen exposure in sex workers sustains changes in the cervical and vaginal micro-environment in a way that may actually increase HIV resistance.

Nepalese authorities on Sunday confiscated 90 cargo containers loaded with products of Dabur Nepal bound for India from the Sirsiya dry port in Birgunj district.

Winter air affects our skin in several ways and makes it dry and itchy. This is when the magical properties of cocoa, banana and mulberry act best by moisturizing skin from deep within, say experts.

A specialised psychotherapy has been linked to changes in activation patterns in certain areas of the brain in patients with borderline personality disorder (BPD), says a study, implying the treatment's impact may go deeper than symptom change.

Combining radiation treatment with 'suicide gene therapy' - a technique in which prostate cancer cells are genetically modified so they signal a patient's immune system to attack them - provides an effective two-pronged punch against the disease, new research shows.